Dewaxing solution for pathology is a colorless and odorless organic solvent specially designed for the treatment of histopathology and cytology samples. It does not contain aromatic compounds and is an environmentally friendly substitute for xylene. It can be used in tissue dehydration and staining process. It is non-corrosive to the instrument and does not need to change the original procedure. It is safe, non-toxic, and has no peculiar smell. The transparent effect is the same as that of xylene. Soaking the tissue for a long time will not make the tissue brittle, but also enhance the effect of wax dipping, which is beneficial to sectioning.
The global Dewaxing Solution for Pathology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dewaxing Solution for Pathology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dewaxing Solution for Pathology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dewaxing Solution for Pathology include Thermo Fisher Scientific, Leica Biosystems, MERCK, Celnovte Biotechnology, Biocare Medical, Sakura Finetek, Elabscience, Biohippo and Omicsbio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dewaxing Solution for Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dewaxing Solution for Pathology.
Report Scope
The Dewaxing Solution for Pathology market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dewaxing Solution for Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dewaxing Solution for Pathology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific
Leica Biosystems
MERCK
Celnovte Biotechnology
Biocare Medical
Sakura Finetek
Elabscience
Biohippo
Omicsbio
Wuhan Servicebio Technology
KOHYPATH
Shanghai Aobo Pharmtech
Beijing Solarbio Science and Technology
Hefei All Things Biotechnology
BeiJing JiuZhou BaiLin Biological and Technology
Shanghai Maokang Biotechnology
Segment by Type
With Xylene
Without Xylene
Segment by Application
Hospital
Clinic
Biology laboratory
Institute
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dewaxing Solution for Pathology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dewaxing Solution for Pathology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Dewaxing Solution for Pathology 麻豆原创 Overview
1.1 Product Overview and Scope of Dewaxing Solution for Pathology
1.2 Dewaxing Solution for Pathology Segment by Type
1.2.1 Global Dewaxing Solution for Pathology 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 With Xylene
1.2.3 Without Xylene
1.3 Dewaxing Solution for Pathology Segment by Application
1.3.1 Global Dewaxing Solution for Pathology 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Biology laboratory
1.3.5 Institute
1.3.6 Others
1.4 Global Dewaxing Solution for Pathology 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Dewaxing Solution for Pathology Revenue 2019-2030
1.4.2 Global Dewaxing Solution for Pathology Sales 2019-2030
1.4.3 Global Dewaxing Solution for Pathology 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dewaxing Solution for Pathology 麻豆原创 Competition by Manufacturers
2.1 Global Dewaxing Solution for Pathology Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Dewaxing Solution for Pathology Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Dewaxing Solution for Pathology Average Price by Manufacturers (2019-2024)
2.4 Global Dewaxing Solution for Pathology Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dewaxing Solution for Pathology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dewaxing Solution for Pathology, Product Type & Application
2.7 Dewaxing Solution for Pathology 麻豆原创 Competitive Situation and Trends
2.7.1 Dewaxing Solution for Pathology 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dewaxing Solution for Pathology Players 麻豆原创 Share by Revenue
2.7.3 Global Dewaxing Solution for Pathology 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dewaxing Solution for Pathology Retrospective 麻豆原创 Scenario by Region
3.1 Global Dewaxing Solution for Pathology 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dewaxing Solution for Pathology Global Dewaxing Solution for Pathology Sales by Region: 2019-2030
3.2.1 Global Dewaxing Solution for Pathology Sales by Region: 2019-2024
3.2.2 Global Dewaxing Solution for Pathology Sales by Region: 2025-2030
3.3 Global Dewaxing Solution for Pathology Global Dewaxing Solution for Pathology Revenue by Region: 2019-2030
3.3.1 Global Dewaxing Solution for Pathology Revenue by Region: 2019-2024
3.3.2 Global Dewaxing Solution for Pathology Revenue by Region: 2025-2030
3.4 North America Dewaxing Solution for Pathology 麻豆原创 Facts & Figures by Country
3.4.1 North America Dewaxing Solution for Pathology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dewaxing Solution for Pathology Sales by Country (2019-2030)
3.4.3 North America Dewaxing Solution for Pathology Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dewaxing Solution for Pathology 麻豆原创 Facts & Figures by Country
3.5.1 Europe Dewaxing Solution for Pathology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dewaxing Solution for Pathology Sales by Country (2019-2030)
3.5.3 Europe Dewaxing Solution for Pathology Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dewaxing Solution for Pathology 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Dewaxing Solution for Pathology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dewaxing Solution for Pathology Sales by Country (2019-2030)
3.6.3 Asia Pacific Dewaxing Solution for Pathology Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dewaxing Solution for Pathology 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Dewaxing Solution for Pathology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dewaxing Solution for Pathology Sales by Country (2019-2030)
3.7.3 Latin America Dewaxing Solution for Pathology Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dewaxing Solution for Pathology 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Dewaxing Solution for Pathology 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dewaxing Solution for Pathology Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dewaxing Solution for Pathology Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dewaxing Solution for Pathology Sales by Type (2019-2030)
4.1.1 Global Dewaxing Solution for Pathology Sales by Type (2019-2024)
4.1.2 Global Dewaxing Solution for Pathology Sales by Type (2025-2030)
4.1.3 Global Dewaxing Solution for Pathology Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Dewaxing Solution for Pathology Revenue by Type (2019-2030)
4.2.1 Global Dewaxing Solution for Pathology Revenue by Type (2019-2024)
4.2.2 Global Dewaxing Solution for Pathology Revenue by Type (2025-2030)
4.2.3 Global Dewaxing Solution for Pathology Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Dewaxing Solution for Pathology Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dewaxing Solution for Pathology Sales by Application (2019-2030)
5.1.1 Global Dewaxing Solution for Pathology Sales by Application (2019-2024)
5.1.2 Global Dewaxing Solution for Pathology Sales by Application (2025-2030)
5.1.3 Global Dewaxing Solution for Pathology Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Dewaxing Solution for Pathology Revenue by Application (2019-2030)
5.2.1 Global Dewaxing Solution for Pathology Revenue by Application (2019-2024)
5.2.2 Global Dewaxing Solution for Pathology Revenue by Application (2025-2030)
5.2.3 Global Dewaxing Solution for Pathology Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Dewaxing Solution for Pathology Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Dewaxing Solution for Pathology Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Leica Biosystems
6.2.1 Leica Biosystems Corporation Information
6.2.2 Leica Biosystems Description and Business Overview
6.2.3 Leica Biosystems Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Leica Biosystems Dewaxing Solution for Pathology Product Portfolio
6.2.5 Leica Biosystems Recent Developments/Updates
6.3 MERCK
6.3.1 MERCK Corporation Information
6.3.2 MERCK Description and Business Overview
6.3.3 MERCK Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MERCK Dewaxing Solution for Pathology Product Portfolio
6.3.5 MERCK Recent Developments/Updates
6.4 Celnovte Biotechnology
6.4.1 Celnovte Biotechnology Corporation Information
6.4.2 Celnovte Biotechnology Description and Business Overview
6.4.3 Celnovte Biotechnology Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Celnovte Biotechnology Dewaxing Solution for Pathology Product Portfolio
6.4.5 Celnovte Biotechnology Recent Developments/Updates
6.5 Biocare Medical
6.5.1 Biocare Medical Corporation Information
6.5.2 Biocare Medical Description and Business Overview
6.5.3 Biocare Medical Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biocare Medical Dewaxing Solution for Pathology Product Portfolio
6.5.5 Biocare Medical Recent Developments/Updates
6.6 Sakura Finetek
6.6.1 Sakura Finetek Corporation Information
6.6.2 Sakura Finetek Description and Business Overview
6.6.3 Sakura Finetek Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sakura Finetek Dewaxing Solution for Pathology Product Portfolio
6.6.5 Sakura Finetek Recent Developments/Updates
6.7 Elabscience
6.6.1 Elabscience Corporation Information
6.6.2 Elabscience Description and Business Overview
6.6.3 Elabscience Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elabscience Dewaxing Solution for Pathology Product Portfolio
6.7.5 Elabscience Recent Developments/Updates
6.8 Biohippo
6.8.1 Biohippo Corporation Information
6.8.2 Biohippo Description and Business Overview
6.8.3 Biohippo Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biohippo Dewaxing Solution for Pathology Product Portfolio
6.8.5 Biohippo Recent Developments/Updates
6.9 Omicsbio
6.9.1 Omicsbio Corporation Information
6.9.2 Omicsbio Description and Business Overview
6.9.3 Omicsbio Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Omicsbio Dewaxing Solution for Pathology Product Portfolio
6.9.5 Omicsbio Recent Developments/Updates
6.10 Wuhan Servicebio Technology
6.10.1 Wuhan Servicebio Technology Corporation Information
6.10.2 Wuhan Servicebio Technology Description and Business Overview
6.10.3 Wuhan Servicebio Technology Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wuhan Servicebio Technology Dewaxing Solution for Pathology Product Portfolio
6.10.5 Wuhan Servicebio Technology Recent Developments/Updates
6.11 KOHYPATH
6.11.1 KOHYPATH Corporation Information
6.11.2 KOHYPATH Dewaxing Solution for Pathology Description and Business Overview
6.11.3 KOHYPATH Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.11.4 KOHYPATH Dewaxing Solution for Pathology Product Portfolio
6.11.5 KOHYPATH Recent Developments/Updates
6.12 Shanghai Aobo Pharmtech
6.12.1 Shanghai Aobo Pharmtech Corporation Information
6.12.2 Shanghai Aobo Pharmtech Dewaxing Solution for Pathology Description and Business Overview
6.12.3 Shanghai Aobo Pharmtech Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Aobo Pharmtech Dewaxing Solution for Pathology Product Portfolio
6.12.5 Shanghai Aobo Pharmtech Recent Developments/Updates
6.13 Beijing Solarbio Science and Technology
6.13.1 Beijing Solarbio Science and Technology Corporation Information
6.13.2 Beijing Solarbio Science and Technology Dewaxing Solution for Pathology Description and Business Overview
6.13.3 Beijing Solarbio Science and Technology Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Beijing Solarbio Science and Technology Dewaxing Solution for Pathology Product Portfolio
6.13.5 Beijing Solarbio Science and Technology Recent Developments/Updates
6.14 Hefei All Things Biotechnology
6.14.1 Hefei All Things Biotechnology Corporation Information
6.14.2 Hefei All Things Biotechnology Dewaxing Solution for Pathology Description and Business Overview
6.14.3 Hefei All Things Biotechnology Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hefei All Things Biotechnology Dewaxing Solution for Pathology Product Portfolio
6.14.5 Hefei All Things Biotechnology Recent Developments/Updates
6.15 BeiJing JiuZhou BaiLin Biological and Technology
6.15.1 BeiJing JiuZhou BaiLin Biological and Technology Corporation Information
6.15.2 BeiJing JiuZhou BaiLin Biological and Technology Dewaxing Solution for Pathology Description and Business Overview
6.15.3 BeiJing JiuZhou BaiLin Biological and Technology Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.15.4 BeiJing JiuZhou BaiLin Biological and Technology Dewaxing Solution for Pathology Product Portfolio
6.15.5 BeiJing JiuZhou BaiLin Biological and Technology Recent Developments/Updates
6.16 Shanghai Maokang Biotechnology
6.16.1 Shanghai Maokang Biotechnology Corporation Information
6.16.2 Shanghai Maokang Biotechnology Dewaxing Solution for Pathology Description and Business Overview
6.16.3 Shanghai Maokang Biotechnology Dewaxing Solution for Pathology Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shanghai Maokang Biotechnology Dewaxing Solution for Pathology Product Portfolio
6.16.5 Shanghai Maokang Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dewaxing Solution for Pathology Industry Chain Analysis
7.2 Dewaxing Solution for Pathology Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dewaxing Solution for Pathology Production Mode & Process
7.4 Dewaxing Solution for Pathology Sales and 麻豆原创ing
7.4.1 Dewaxing Solution for Pathology Sales Channels
7.4.2 Dewaxing Solution for Pathology Distributors
7.5 Dewaxing Solution for Pathology Customers
8 Dewaxing Solution for Pathology 麻豆原创 Dynamics
8.1 Dewaxing Solution for Pathology Industry Trends
8.2 Dewaxing Solution for Pathology 麻豆原创 Drivers
8.3 Dewaxing Solution for Pathology 麻豆原创 Challenges
8.4 Dewaxing Solution for Pathology 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fisher Scientific
Leica Biosystems
MERCK
Celnovte Biotechnology
Biocare Medical
Sakura Finetek
Elabscience
Biohippo
Omicsbio
Wuhan Servicebio Technology
KOHYPATH
Shanghai Aobo Pharmtech
Beijing Solarbio Science and Technology
Hefei All Things Biotechnology
BeiJing JiuZhou BaiLin Biological and Technology
Shanghai Maokang Biotechnology
听
听
*If Applicable.
